摘要
目的:研究凋亡抑制蛋白FL IP,C aspase8,肿瘤转移相关基因M TA 1在上皮性卵巢肿瘤中表达及其意义,探讨它们与卵巢癌临床病理指标之间的关系。方法:应用免疫组化SP法,检测FL IP、C aspase8、M TA 1在98例上皮性卵巢肿瘤(包括18例良性囊腺瘤,20例交界性囊腺瘤和60例卵巢癌)的表达情况。结果:FL IP、C aspase8及M TA 1在卵巢交界性囊腺瘤和卵巢癌中的表达均分别明显高于卵巢良性囊腺瘤(P<0.05),FL IP、M TA 1的表达在组织学分型、分化程度之间无显著性差异(P>0.05)。而与卵巢癌的F IGO分期及有无转移之间有显著性差异(P<0.05)。并且FLAP和C aspase8成负相关关系。结论:FL IP、M TA 1在卵巢癌中的发生发展中起重要作用。期望能为判断卵巢癌的生物学行为,决定治疗方案提供理论依据。
ObjectiveTo investigate the expression of FLIP ,Caspase 8 and MTA1 in human epithelial ovarian tumor and analyze its clinical significance. Methods:The expression of FLIP,Caspase 8 and MTA1 was detected by immunohisloehemical techniques in 48 patients with epithelial ovarian tumors (18 benign, 20 borderline and 60 malignant ones). Results:The expression of FLIP, Caspase8 and MTA1 showed a significant difference between benign and borderline or malignant tumors ( P〈0. 05 ). The expression of FLIP and MTA1 had difference between the FIGO stage and metastasis( P 〈0.05) . There was a negative correlation between FLIP and Caspase 8. Conclusion:Overexpression of FLIP and MTA1 in ovarian tumor may play an important role in tumor development and progression. Detection of the FLIP,Caspase 8 and MTA1 may have potential effects on biological behaviors of the tumor,providing the theoretical basis for therapy.
出处
《黑龙江医药科学》
2006年第6期34-35,共2页
Heilongjiang Medicine and Pharmacy